BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+27.77%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$8.73B
AUM Growth
+$1.49B
(+21%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
234
New
17
Increased
80
Reduced
68
Closed
12
Top Buys
| 1 |
Biogen
BIIB
|
$136M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$65.8M |
| 3 |
Mersana Therapeutics
MRSN
|
$51.3M |
| 4 |
Arvinas
ARVN
|
$46.7M |
| 5 |
AbbVie
ABBV
|
$36.3M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$154M |
| 2 |
Halozyme
HALO
|
$60.8M |
| 3 |
Pacific Biosciences
PACB
|
$57.2M |
| 4 |
CareDx
CDNA
|
$55.9M |
| 5 |
Charles River Laboratories
CRL
|
$52M |
Sector Composition
| 1 | Healthcare | 95.9% |
| 2 | Technology | 0.6% |
| 3 | Industrials | 0.33% |
| 4 | Financials | 0.11% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Brown-Forman Class B
BF.B
$13.6B
| $445K | 0.01% |
5,600
-2,000
| -26% | -$159K |
|
202
Booking.com
BKNG
$178B
| $445K | 0.01% |
200
| – | – |
|
203
Trip.com Group
TCOM
$47.8B
| $442K | 0.01% |
13,100
| – | – |
|
204
American Express
AXP
$226B
| $435K | 0.01% |
3,600
| – | – |
|
205
Moody's
MCO
$89.2B
| $435K | 0.01% |
1,500
-500
| -25% | -$145K |
|
206
Factset
FDS
$14B
| $432K | ﹤0.01% |
1,300
-400
| -24% | -$133K |
|
207
Fortinet
FTNT
$60.7B
| $431K | ﹤0.01% |
14,500
| – | – |
|
208
Skyworks Solutions
SWKS
$11.1B
| $428K | ﹤0.01% |
2,800
-900
| -24% | -$138K |
|
209
Tradeweb Markets
TW
$25.4B
| $425K | ﹤0.01% |
6,800
| – | – |
|
210
McKesson
MCK
$85.5B
| $423K | ﹤0.01% |
2,430
-1,462
| -38% | -$254K |
|
211
McCormick & Company Non-Voting
MKC
$19B
| $421K | ﹤0.01% |
4,400
-1,200
| -21% | -$115K |
|
212
Service Corp International
SCI
$10.9B
| $417K | ﹤0.01% |
8,500
| – | – |
|
213
Markel Group
MKL
$24.2B
| $413K | ﹤0.01% |
400
| – | – |
|
214
Watsco
WSO
$16.5B
| $408K | ﹤0.01% |
1,800
-1,000
| -36% | -$227K |
|
215
Clorox
CLX
$15.6B
| $404K | ﹤0.01% |
2,000
| – | – |
|
216
S&P Global
SPGI
$164B
| $394K | ﹤0.01% |
1,200
-500
| -29% | -$164K |
|
|
AZPN
217
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $391K | ﹤0.01% |
3,000
| – | – |
|
218
Domino's
DPZ
$15.6B
| $383K | ﹤0.01% |
1,000
| – | – |
|
219
Blackbaud
BLKB
$3.21B
| $236K | ﹤0.01% |
4,107
| – | – |
|
|
ICPT
220
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $198K | ﹤0.01% |
8,000
-696,976
| -99% | -$17.3M |
|
221
Viatris
VTRS
$12.2B
| $172K | ﹤0.01% |
+9,169
| New | +$172K |
|
|
CVET
222
DELISTED
Covetrus, Inc. Common Stock
CVET
| $44K | ﹤0.01% |
1,520
| – | – |
|
223
Adobe
ADBE
$147B
| – | – |
-1,100
| Closed | -$539K |
|
224
Huazhu Hotels Group
HTHT
$11.4B
| – | – |
-13,500
| Closed | -$584K |
|
225
Integra LifeSciences
IART
$1.25B
| – | – |
-122,426
| Closed | -$5.78M |
|